Related Experiment Video
Updated: Aug 13, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Optimising chemoradiotherapy in anal cancer
P Franco1,2, L Deantonio3,4,5, R Muirhead6
1Department of Translational Medicine (DIMET), University of Eastern Piedmont, Novara, Italy.
Abstract:
Concurrent chemoradiotherapy is the standard treatment for localised squamous-cell carcinoma of the anus. Even though this approach is well established, research efforts are ongoing to optimise this therapeutic option to maximise oncological outcomes, decrease treatment-related toxicity profile, and optimise health-related quality of life. We provide an overview of the available data and the active fields of research in the optimisation of chemoradiotherapy in anal cancer patients.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis